PI
AMRI

PineBridge Investments’s Albany Molecular Research Inc AMRI Stock Holding History

PineBridge Investments’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,940
Closed -$64K – 1227
2017
Q2 		$64K Buy
2,940
+31
+1% +$563 ﹤0.01% 993
2017
Q1 		$41K Buy
2,909
+75
+3% +$1.23K ﹤0.01% 1047
2016
Q4 		$53K Hold
2,834
– – ﹤0.01% 1073
2016
Q3 		$47K Sell
2,834
-337
-11% -$4.99K ﹤0.01% 977
2016
Q2 		$42K Hold
3,171
– – ﹤0.01% 984
2016
Q1 		$48K Sell
3,171
-451
-12% -$7.07K ﹤0.01% 926
2015
Q4 		$71K Buy
3,622
+330
+10% +$6.27K ﹤0.01% 873
2015
Q3 		$57K Buy
3,292
+485
+17% +$9.88K ﹤0.01% 900
2015
Q2 		$57K Sell
2,807
-3,049
-52% -$58.8K ﹤0.01% 918
2015
Q1 		$103K Buy
5,856
+508
+9% +$8.66K ﹤0.01% 905
2014
Q4 		$87K Buy
5,348
+242
+5% +$4.44K ﹤0.01% 941
2014
Q3 		$113K Buy
5,106
+2,227
+77% +$45.6K ﹤0.01% 826
2014
Q2 		$58K Buy
+2,879
New +$48.8K ﹤0.01% 908

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

PineBridge Investments's AMRI Position: Q3 2017 in Review

PineBridge Investments sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 2,940 shares — an estimated $64K sold.

PineBridge Investments first reported a position in AMRI in Q2 2014 and held it in 13 quarters. The position peaked at $113K in Q3 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • PineBridge Investments reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • PineBridge Investments sold 2,940 Albany Molecular Research Inc shares in Q3 2017, an estimated $64K.
  • PineBridge Investments first reported a position in Albany Molecular Research Inc in Q2 2014 and held it in 13 quarters.
  • PineBridge Investments's Albany Molecular Research Inc position peaked at $113K in Q3 2014.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on PineBridge Investments's 13F filing for Q3 2017, filed 13 Nov 2017.